ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2018 to Q4 2025

Type / Class
Equity / Common Shares, no par value per share
Symbol
EPIX
Shares outstanding
47,601,550
Price per share
$0.21
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
22,521,153
Total reported value
$4,301,583
% of total 13F portfolios
0%
Share change
-8,188,589
Value change
-$19,774,211
Number of holders
32
Price from insider filings
$0.21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Soleus Capital Master Fund, L.P. 9.8% +94% $7,415,444 +$3,570,000 4,362,026 +93% SOLEUS CAPITAL MASTER FUND, L.P. 17 Jul 2025
BML Investment Partners, L.P. 9.5% +1.1% $7,598,783 +$68,981 4,221,546 +0.92% BML Investment Partners, L.P. 24 Apr 2025
MORGAN STANLEY 4% $456,975 1,904,062 Morgan Stanley 30 Sep 2025
RTW INVESTMENTS, LP 2.5% $2,003,404 1,113,002 RTW Investments, LP 31 Dec 2024

As of 30 Sep 2025, 32 institutional investors reported holding 22,521,153 shares of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX). This represents 47% of the company’s total 47,601,550 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) together control 47% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BVF INC/IL 25% 11,668,473 +33% 0.09% $2,228,678
Soleus Capital Management, L.P. 9.2% 4,362,026 +93% 0.04% $833,147
MORGAN STANLEY 4% 1,904,061 -55% 0% $363,676
Pfizer Inc 3.5% 1,675,000 0% 0.07% $319,925
BANK OF AMERICA CORP /DE/ 1.2% 591,834 -5.7% 0% $113,041
LMR Partners LLP 1.1% 540,984 +170% 0% $103,328
Shay Capital LLC 1.1% 536,533 +2104% 0.02% $102,478
TWO SIGMA INVESTMENTS, LP 0.71% 336,164 +51% 0% $64,207
TWO SIGMA ADVISERS, LP 0.45% 214,800 -18% 0% $41,027
CITADEL ADVISORS LLC 0.3% 144,449 +167% 0% $27,590
CSS LLC/IL 0.22% 103,488 0% $19,766
Virtu Financial LLC 0.16% 77,036 0% $15,000
Yakira Capital Management, Inc. 0.15% 72,123 0.01% $13,775
Magnus Financial Group LLC 0.12% 55,206 0% 0% $10,544
Skandinaviska Enskilda Banken AB (publ) 0.11% 51,973 0% $9,927
XTX Topco Ltd 0.1% 45,524 +7.9% 0% $8,695
Algorithmic Investment Models, LLC 0.06% 28,225 0% $5,391
GEODE CAPITAL MANAGEMENT, LLC 0.05% 23,840 0% 0% $4,553
SIMPLEX TRADING, LLC 0.04% 20,381 0% $3,000
ROYAL BANK OF CANADA 0.04% 19,156 +2738% 0% $4,000
Belvedere Trading LLC 0.03% 15,201 0% $2,903
BNP PARIBAS FINANCIAL MARKETS 0.02% 9,800 0% 0% $1,872
BlackRock, Inc. 0.01% 7,074 0% 0% $1,351
OSAIC HOLDINGS, INC. 0.01% 6,000 0% 0% $1,440
UBS Group AG 0.01% 5,470 -54% 0% $1,045

Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$10,544 $0.21 0
2025 Q3 22,521,153 $4,301,583 -$19,774,211 $0.19 32
2025 Q2 30,970,782 $52,650,184 -$1,127,767 $1.70 35
2025 Q1 31,681,355 $50,056,171 -$2,246,323 $1.58 35
2024 Q4 32,829,217 $58,763,166 -$67,554,468 $1.79 44
2024 Q3 35,103,052 $212,724,662 +$269,717 $6.06 32
2024 Q2 35,208,390 $185,094,881 +$787,443 $5.26 31
2024 Q1 35,037,057 $297,463,581 +$2,481,095 $8.49 33
2023 Q4 34,772,388 $229,436,154 +$13,901,733 $6.60 31
2023 Q3 33,469,182 $103,416,891 +$681,859 $3.09 36
2023 Q2 33,249,423 $89,773,501 +$345,204 $2.70 38
2023 Q1 33,092,147 $98,277,629 +$349,180 $2.97 36
2022 Q4 33,368,813 $84,091,085 +$2,320,053 $2.52 43
2022 Q3 33,417,334 $60,814,684 -$15,060,697 $1.82 49
2022 Q2 37,773,975 $118,994,687 -$275,773 $3.15 55
2022 Q1 37,197,195 $229,891,130 -$37,768,183 $6.18 66
2021 Q4 37,334,475 $530,072,278 +$7,512,573 $14.20 58
2021 Q3 37,173,724 $297,437,064 -$67,533,896 $8.00 74
2021 Q2 34,155,853 $975,990,399 +$94,781,085 $28.57 78
2021 Q1 30,834,019 $895,742,171 +$247,196,452 $29.05 68
2020 Q4 23,117,706 $274,324,124 +$29,029,638 $11.93 38
2020 Q3 20,317,336 $139,156,228 +$43,178,452 $6.90 33
2020 Q2 14,061,425 $86,521,104 -$1,180,827 $6.20 19
2020 Q1 14,249,424 $56,595,712 +$1,185,503 $4.00 15
2019 Q4 13,929,616 $76,086,979 +$219,855 $5.50 18
2019 Q3 12,232,081 $40,883,600 +$22,644,720 $3.37 12
2019 Q2 5,481,234 $13,087,000 +$3,840,427 $2.45 7
2019 Q1 3,828,813 $13,059,000 +$208 $3.40 7
2018 Q4 3,828,750 $8,040,000 +$3,510,215 $2.10 7
2018 Q3 3,825,113 $6,525,006 +$3,200,797 $3.00 7
2018 Q2 2,749,482 $10,410,000 +$10,410,000 $3.78 6